Nabriva Therapeutics plc
NBRV
Rank in Stocks
#39903
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Share Price
$0.63
Last synced: 2023-08-29
Market Cap
$284.20K
Change (1 day)
-21.25%
Change (1 year)
629,900.02%
Country
IE
Trade Nabriva Therapeutics plc (NBRV)
Category
Healthcare
Stock split history for Nabriva Therapeutics plc (NBRV)
Nabriva Therapeutics plc stock (symbol: NBRV) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One NBRV share bought prior to Oct 20, 2026 would equal to 0 NBRV shares today.
The most recent stock split occurred on Oct 20, 2026.
One NBRV share bought prior to Oct 20, 2026 would equal to 0 NBRV shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
